Drug utilisation pattern over 3 years in the real-world treatment of type II diabetes.

Alessia RomagnoliFiorenzo SantoleriAlberto Costantini

Published in: International journal of clinical practice (2021)

Adherence to therapy was suboptimal, while persistence curves showed a statistically significant difference, with patients treated with metformin showing better results. Comorbidities analysed showed a greater relevance of heart disease.

Keyphrases

type diabetes
glycemic control
cardiovascular disease
pulmonary hypertension
stem cells
emergency department
metabolic syndrome
mesenchymal stem cells
adipose tissue
bone marrow
drug induced
electronic health record